![Equilibre Attitude (EA Pharma) strengthens its expertise in Oligotherapy with the acquisition of Labcatal, its third build-up under Motion ownership - Motion Equity Partners Equilibre Attitude (EA Pharma) strengthens its expertise in Oligotherapy with the acquisition of Labcatal, its third build-up under Motion ownership - Motion Equity Partners](https://www.motionequitypartners.com/wp-content/uploads/2020/02/New-Project-20-1-1.jpg)
Equilibre Attitude (EA Pharma) strengthens its expertise in Oligotherapy with the acquisition of Labcatal, its third build-up under Motion ownership - Motion Equity Partners
![Pathalys Pharma, Inc. Launches with Mission to Address High Priority Needs in Chronic Kidney Disease - Catalys Pacific Pathalys Pharma, Inc. Launches with Mission to Address High Priority Needs in Chronic Kidney Disease - Catalys Pacific](https://catalyspacific.com/wp-content/uploads/2022/03/news-default-01.jpeg)
Pathalys Pharma, Inc. Launches with Mission to Address High Priority Needs in Chronic Kidney Disease - Catalys Pacific
![Ea Pharma Restor Kuwait Online | Fish oil + Omega 3, Supplements, Vitamins and Supplements, Pharmacy products in Kuwait Online Ea Pharma Restor Kuwait Online | Fish oil + Omega 3, Supplements, Vitamins and Supplements, Pharmacy products in Kuwait Online](https://pharmatee.com/wp-content/uploads/2019/10/ea-pharma-restor-600x600.jpg)
Ea Pharma Restor Kuwait Online | Fish oil + Omega 3, Supplements, Vitamins and Supplements, Pharmacy products in Kuwait Online
![EA Pharma strengthens its international presence with the acquisition of the Spanish Group DRASANVI, its fourth build-up with Motion - Motion Equity Partners EA Pharma strengthens its international presence with the acquisition of the Spanish Group DRASANVI, its fourth build-up with Motion - Motion Equity Partners](https://www.motionequitypartners.com/wp-content/uploads/2021/08/New-Project-1.jpg)